Cutler Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-791
Closed -$39K 5653
2017
Q3
$39K Buy
791
+500
+172% +$25.5K ﹤0.01% 2476
2017
Q2
$15K Sell
291
-200
-41% -$10.7K ﹤0.01% 3732
2017
Q1
$27K Buy
+491
New +$27.1K ﹤0.01% 3025
2016
Q3
Sell
-2,047
Closed -$104K 7191
2016
Q2
$113K Sell
2,047
-293
-13% -$16.1K 0.01% 1581
2016
Q1
$124K Buy
2,340
+2,300
+5,750% +$113K 0.01% 1415
2015
Q4
$2K Buy
+40
New +$1.99K ﹤0.01% 5607

Other funds holding PBH

Cutler Group's PBH Position: Q4 2017 in Review

Cutler Group sold out of Prestige Consumer Healthcare (PBH) in Q4 2017, closing a stake of 791 shares — an estimated $39K sold.

Cutler Group first reported a position in PBH in Q4 2015 and held it in 6 quarters. The position peaked at $124K in Q1 2016. 251 funds tracked by Wall St. Rank hold PBH as of Q4 2017.

  • Cutler Group reported no remaining Prestige Consumer Healthcare position as of Q4 2017 after selling out during the quarter.
  • Cutler Group sold 791 Prestige Consumer Healthcare shares in Q4 2017, an estimated $39K.
  • Cutler Group first reported a position in Prestige Consumer Healthcare in Q4 2015 and held it in 6 quarters.
  • Cutler Group's Prestige Consumer Healthcare position peaked at $124K in Q1 2016.
  • 251 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2017.

Based on Cutler Group's 13F filing for Q4 2017, filed 17 Jan 2018.